Genistein, an inhibitor of tyrosine kinase, prevents the antiarrhythmic effects of preconditioning
- 1 October 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 338 (1) , 67-70
- https://doi.org/10.1016/s0014-2999(97)01299-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat heartsFEBS Letters, 1996
- Delayed protection against ischaemia‐induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia coli endotoxinBritish Journal of Pharmacology, 1996
- Delayed protection of the heart against ischaemiaTrends in Pharmacological Sciences, 1995
- Tyrosine-kinase-dependent signaling pathwaysTrends in Cardiovascular Medicine, 1994
- "Dose"-dependency and Temporal Characteristics of Protection by Ischaemic Preconditioning against Ischaemia-induced Arrhythmias in Rat HeartsJournal of Molecular and Cellular Cardiology, 1993
- Endogenous myocardial protective (antiarrhythmic) substancesCardiovascular Research, 1993
- The antiarrhythmic effect of ischaemic preconditioning in isolated rat heart involves a pertussis toxin sensitive mechanismCardiovascular Research, 1993
- Antiarrhythmic effects of preconditioning in anaesthetised dogs and ratsCardiovascular Research, 1992
- Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase productsCardiovascular Research, 1990
- The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusionCardiovascular Research, 1988